Acid Reducer Tablet, Delayed Release
NDC Package 69842-679-14
Package Information
Acid Reducer (esomeprazole magnesium) tablets is ranitidine is known as an H2 blocker. This formulation utilizes a tablet, delayed release delivery system. Marketed by Cvs Pharmacy, this product is identified by NDC 69842-679 and is authorized under FDA application ANDA212088.
Identification & Billing
- RxCUI: 433733 - esomeprazole magnesium 20 MG Delayed Release Oral Tablet
- RxCUI: 433733 - esomeprazole 20 MG Delayed Release Oral Tablet
- RxCUI: 433733 - esomeprazole 20 MG (as esomeprazole magnesium 22.3 MG) Delayed Release Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 69842 - Cvs Pharmacy
- 69842-679 - Acid Reducer
- 69842-679-14 - 1 BOTTLE, PLASTIC in 1 CARTON / 14 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC
- 69842-679 - Acid Reducer
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (69842-679). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 69842-679-14 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 14 tablet, delayed release in 1 bottle, plastic of Acid Reducer, a human over the counter drug labeled by Cvs Pharmacy. This tablet, delayed release is formulated for oral use and contains esomeprazole magnesium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cvs Pharmacy on December 31, 2021.
What are the primary indications for this medication?
Ranitidine is known as an H2 blocker. It works by reducing the amount of acid in your stomach. It is used to prevent and treat heartburn and other symptoms caused by too much acid in the stomach (acid indigestion). This drug has been withdrawn from the US market due to problems with safety. A possible cancer-causing impurity has been found in some ranitidine products.
How is this Cvs Pharmacy product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 69842067914. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.